EUROPE Human Microbiome market is expected to reach US$ 5,008.93 Bn by 2027 with CAGR of 7%.

All News

The Europe human microbiome market is expected to reach US$ 346.67 Mn in 2025 from US$ 72.34 in 2017. The market is estimated to grow with a CAGR of 22.2% from 2018-2025.

The growth of the market is driven by the factors such alarming rise in non-communicable diseases (NCDS), rising efforts in the development of human microbiome based therapies and developments in genomics and sequencing techniques. Whereas, rigorous government regulations for advanced therapies and limited understanding is likely to have a negative impact on the growth of the market in the coming years.

Fecal microbiota transplantation (FMT) has developed as an effective treatment for C. difficile infection (CDI) refractory towards antibiotic therapy. The microbiota have important roles in the function of gastrointestinal tract and other aspects of human physiology, there is also growing interest in studying FMT for other clinical indications. The US Food and Drug Administration (FDA) has classified human stool as a biological agent and determined that its use in fecal microbiota transplantation (FMT) therapy and other research are regulated for the insurance of patient safety. With the use of FMT in the treatment of recurrent Clostridium difficile infection (RCDI), an investigational new drug (IND) permit is not required, but is strongly encouraged and may ultimately be required.

Get free trial subscription and gain instant access to our market research reports at

https://www.businessmarketinsights.com/TIPRE00003318/request-trial

Germany is anticipated to lead the adoptions of Human microbiome across the Europe region through the forecast period. Human microbiome is an emerging field in the country and the developments are being conducted widely in the country. The genome-wide association analysis study carried out in Germany was published in 2016. The study identifies variation in vitamin D receptor and other host factors influence the gut microbiota.

The Business Market Insights subscription helps clients understand the ongoing market trends, identify opportunities, and make informed decisions through the reports in the Subscription Platform. The Industry reports available in the subscription provide an in-depth analysis on various market topics and enable clients to line up remunerative opportunities. The reports provide the market size & forecast, drivers, challenges, trends, and more.

Business Market Insights reports focus upon client objectives, use standard research methodologies and exclusive analytical models, combined with robust business acumen, which provides precise and insightful results.

Business Market Insights reports are useful not only for corporate and academic professionals but also for consulting, research firms, PEVC firms, and professional services firms.

EUROPE HUMAN MICROBIOME- MARKET SEGMENTATION

By Product

• Probiotics

• Foods

• Prebiotics

• Medical Foods

• Diagnostic Device

• Drugs

• Supplements

EUROPE HUMAN MICROBIOME- MARKET SEGMENTATION

By Disease

• Obesity

• Diabetes

• Autoimmune Disorders

• Cancer

• Mental Disorders

• Others

EUROPE HUMAN MICROBIOME- MARKET SEGMENTATION

By Application

• Therapeutics

• Diagnostics

By Country

• U.S.

• Canada

• Mexico

Companies Mentioned

• Enterome

• MicroBiome Therapeutics, LLC

• Rebiotix Inc.

• Yakult Honsha Co., Ltd.

• Osel Inc.

• Vedanta Biosciences, Inc.

• Metabiomics Corporate

• Synthetic Biologics, Inc.

• DuPont

• BiomX Ltd.

Full Report subscription with pay as per requirement at

(30-day subscription plans prove to be very cost-effective with no compromise on the quality of reports)

https://www.businessmarketinsights.com/TIPRE00003318/checkout/basic/single/monthly

Benefits with Business Market Insights

About Business Market Insights

Based in New York, Business Market Insights is a one-stop destination for in-depth market research reports from various industries including Technology, Media & Telecommunications, Semiconductor & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Technology, Media and Telecommunications  IT, Manufacturing & Construction, Medical Device, and Chemicals & Materials. The clients include corporate and academic professionals, consulting, research firms, PEVC firms, and professional services firms.

For Subscription contact

Business Market Insights

Phone : +442081254005
E-Mail : [email protected]